Skip to main content
Fig. 4 | International Journal of Retina and Vitreous

Fig. 4

From: Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab

Fig. 4

An 89-year-old female patient who received 5 bevacizumab and 6 ranibizumab injections in the year before baseline and 8 aflibercept injections in 1 year of follow up. She showed good response to aflibercept with marked improvement of intraretinal fluid after the first aflibercept injection followed by gradual resolution thereafter, with residual few extrafoveal cysts at last follow-up visit. a Baseline, b Month 1, c Month 3, d Month 6, e Month 12

Back to article page
\